Eli Lilly’s growth tied to nascent diabetes drug sales
(Reuters) – Wall Street analysts will be focusing on sales of Eli Lilly and Co’s newly approved diabetes drug Mounjaro when the company reports results on Tuesday, as sales of its older…
